polyneuropathy
Information
- Disease name
- polyneuropathy
- Disease ID
- DOID:1389
- Description
- "A peripheral system disease that is characterized by damage affecting peripheral nerves (peripheral neuropathy) in roughly the same areas on both sides of the body, featuring weakness, numbness, pins-and-needles, and burning pain." [url:https\://en.wikipedia.org/wiki/Polyneuropathy, url:https\://www.virginiamason.org/polyneuropathy]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT00259974 | Completed | Phase 3 | RIMAG Study: Trial of Rituximab Versus Placebo in Polyneuropathy Associated With Anti-MAG IgM Monoclonal Gammopathy | April 2006 | January 2010 |
| NCT00614562 | Completed | Phase 1 | Neurally Adjusted Ventilatory Assist (NAVA) in Patients With Critical Illness Associated Polyneuropathy / or Polymyopathy (CIP/M) | January 2008 | December 2010 |
| NCT01076478 | Completed | Phase 4 | Asian Study on Cilostazol Effectivity in Neuropathies of Diabetes Mellitus Type 2-A Pilot Study in the Philippines | March 2004 | November 2009 |
| NCT01302275 | Completed | Phase 4 | Oxcarbazepine for the Treatment of Chronic Peripheral Neuropathic Pain | February 2011 | May 2013 |
| NCT01450163 | Completed | Phase 3 | Evaluate The Efficacy and Safety Of Pregabalin In Prevention, Reduction of Oxaliplatin-Induced Painful Neuropathy | August 2011 | December 2014 |
| NCT02442986 | Completed | Neurological Outcome in Surgical and Non-surgical Septic Patients | November 2012 | March 2017 | |
| NCT02706314 | Completed | Impact of Human Blood Serum From Critically Ill Patients on Human Colon Neuronal Networks. | March 2016 | April 16, 2019 | |
| NCT02846844 | Completed | Patients With Chemotherapy-induced Polyneuropathy Are Treated With an Integrated Program Including Massage, Mobilization in Posture and Transport Layers, Physical Exercises or With Whole-body Vibration Platform Training | June 2010 | October 2015 | |
| NCT03373370 | Completed | Early Diagnosis of TTR Amyloidosis by Use of Molecular Biology | March 17, 2017 | December 10, 2021 | |
| NCT04201418 | Completed | A Multicenter Observational Study to Evaluate the Effectiveness of Patisiran in Patients With Polyneuropathy of ATTRv Amyloidosis With a V122I or T60A Mutation | December 18, 2019 | May 24, 2022 | |
| NCT05560555 | Completed | Retrospective Study Collecting Neurological Follow-up of Hereditary Transthyretin Amyloidosis (ATTRv) Patients Included in B3461028 and B3461045. | October 24, 2022 | November 15, 2022 | |
| NCT05040373 | Recruiting | Patisiran-Lipid Nanoparticle (LNP) Pregnancy Surveillance Program | August 1, 2020 | October 12, 2030 | |
| NCT05950867 | Recruiting | N/A | Prevalence of Wild-type TTR Cardiac Amyloidosis in Patients With Polyneuropathy of Unknown Cause. | July 28, 2023 | June 1, 2026 |
| NCT06414746 | Recruiting | Hereditary Transthyretin Amyloidosis Polyneuropathy in Patients With Carpal Tunnel Syndrome in Russia | December 29, 2023 | December 31, 2024 | |
| NCT01088256 | Terminated | Phase 2 | Efficacy of Etoricoxib on Peripheral Hyperalgesia | February 2011 | August 2012 |
| NCT00832572 | Terminated | Phase 4 | Study of Ranexa in Patients With Coronary Artery Disease and Painful Polyneuropathy | January 2009 | June 2009 |
| NCT02666456 | Unknown status | The Influence of Sensory Phenotype on the Risk of Developing Neuropathic Pain | April 2016 | ||
| NCT01047488 | Unknown status | Phase 4 | Imipramine and Pregabalin Combination in Painful Polyneuropathy | February 2010 | March 2013 |
| NCT02033057 | Unknown status | Phase 4 | Muscular Electrostimulation of the Sedated and Mechanically Ventilated Critically Ill Patient. Analysis of the Effect on Acquired Muscular Weakness and Its Clinical Consequences. | October 2012 | October 2014 |
| NCT02566941 | Withdrawn | N/A | Neuromuscular Electrical Stimulation in the Critically Ill | October 1, 2015 | May 30, 2018 |
| NCT00723918 | Withdrawn | Phase 2 | Combination of an Investigational Cannabinoid and Methadone for HIV-associated Neuropathy | April 2009 | January 2010 |
- Disase is a (Disease Ontology)
- DOID:574
- Cross Reference ID (Disease Ontology)
- ICD10CM:A69.22
- Cross Reference ID (Disease Ontology)
- MESH:D011115
- Cross Reference ID (Disease Ontology)
- NCI:C26951
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:193166009
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0152025
- HPO alt_id (Human Phenotype Ontology)
- HP:0006941
- HPO alt_id (Human Phenotype Ontology)
- HP:0007287
- HPO Human Phenotype ID (Human Phenotype Ontology)
- HP:0001271
- MedGen concept unique identifier (MedGen Concept name)
- C0152025
- MedGen unique identifier (MedGen Concept name)
- 57502